The presentation analyzed corruption risks in the procurement of medicines, and offered some reflections on the reason why some anti-corruption approaches to procurement of medicines have failed, particularly in light of the dichotomy between the principal-agent and collective action models. Some of the elements elaborated on findings from U4 publications and workshops. In the end, a framework was presented for anti-corruption approaches to medicines procurement. 

The presentation was part of a series of seminars organized by the University of Bergen School for International Health. Some 35 PhD students and health experts attended.